DcpS can act in the 5'-3' mRNA decay pathway in addition to the 3'-5' pathway

Area of Science:

• Molecular Biology
• Gene Expression Regulation
• RNA Metabolism

Background:

• Eukaryotic mRNA degradation involves two main pathways: 3'-5' and 5'-3'.
• Both pathways require mRNA cap breakdown.
• The 5'-3' pathway involves the Dcp2 enzyme, producing m7GDP and 5'-phosphorylated mRNA.

Purpose of the Study:

• To investigate mRNA decay in human cell extracts using a novel decapping assay.
• To identify the products and intermediates of mRNA decapping.
• To elucidate the fate of m7GDP during mRNA decay.

Main Methods:

• Development of a new assay for measuring decapping activity in human cell extracts.
• Incubation of substrate RNA in cell extracts to observe decay intermediates.
• Biochemical analysis to detect and quantify nucleotide products like m7GDP and m7GMP.
• Enzyme identification through activity assays in yeast and human extracts.

Main Results:

• Evidence for an active 5'-3' mRNA decay pathway in human cell extracts was observed.
• 5'-phosphorylated intermediates were detected, but the expected m7GDP product was absent.
• Abundant m7GMP was generated, indicating m7GDP is efficiently converted to m7GMP.
• DcpS was identified as the enzyme responsible for m7GDP to m7GMP conversion in both yeast and human.

Conclusions:

• m7GMP is a general, pathway-independent byproduct of eukaryotic mRNA decay.
• DcpS plays a crucial role in hydrolyzing m7GDP to m7GMP.
• This conversion may prevent nucleotide misincorporation and serve as a cellular mRNA decay monitor.